Gevo, Inc.  

(Public, NASDAQ:GEVO)   Watch this stock  
Find more results for GEVO
1.82
-0.03 (-1.62%)
May 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.80 - 1.91
52 week 1.36 - 9.44
Open 1.84
Vol / Avg. 331,547.00/863,727.00
Mkt cap 74.73M
P/E     -
Div/yield     -
EPS -1.71
Shares 41.06M
Beta     -
Inst. own 62%
Aug 5, 2013
Q2 2013 Gevo, Inc. Earnings Release Add to calendar
Jun 6, 2013
Gevo, Inc. Annual Shareholder Meeting - 5:00PM EDT - Add to calendar
May 30, 2013
Gevo, Inc. at Cowen Technology, Media & Telecom Conference - 2:00PM EDT - Add to calendar
Apr 30, 2013
Q1 2013 Gevo, Inc. Earnings Conference Call - Webcast
Apr 29, 2013
Q1 2013 Gevo, Inc. Earnings Release
Mar 21, 2013
Gevo announces significant win in Butamax litigation and anticipates favorable outcome of August trial - Webcast
Mar 5, 2013
Q4 2012 Gevo, Inc. Earnings Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin -518.49% -248.97%
Operating margin -389.84% -292.95%
EBITD margin - -279.37%
Return on average assets -49.40% -41.99%
Return on average equity -79.43% -63.92%
Employees 120 -
Carbon Disclosure Rating - -

Address

Building C Suite 310, 345 Inverness Drive South Suite 310
ENGLEWOOD, CO 80112
United States - Map
+1-303-8588358 (Phone)
+1-302-6745266 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Gevo, Inc., is a renewable chemicals and advanced biofuels company. The Company is focused on the development and commercialization of alternatives to petroleum-based products. The Company operates in two segments: Gevo, Inc. Segment and Gevo Development/Agri-Energy Segment. Gevo, Inc. Segment is responsible for all research and development activities related to the future production of isobutanol, maintaining and protecting its intellectual property portfolio, developing future markets for its isobutanol and providing corporate oversight services. Its Gevo Development/Agri-Energy Segment is responsible for the production of ethanol and related products. In September 2010, the Company acquired a 22 MGPY ethanol production facility in Luverne, Minnesota that the Company intends to retrofit to produce isobutanol.

Officers and directors

Shai Weiss Independent Chairman of the Board
Age: 43
Bio & Compensation  - Reuters
Christopher Michael Ryan Ph.D. President, Chief Operating Officer, Chief Technology Officer
Age: 50
Bio & Compensation  - Reuters
Patrick R. Gruber Ph.D. Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
Mark L. Smith Chief Financial Officer
Age: 50
Bio & Compensation  - Reuters
Brett Lund J.D. Executive Vice President, General Counsel, Secretary
Age: 36
Bio & Compensation  - Reuters
Ruth I. Dreessen Director
Age: 56
Bio & Compensation  - Reuters
Samir Kaul Director
Bio & Compensation  - Reuters
Gary W. Mize Director
Age: 60
Bio & Compensation  - Reuters
Carlos A. Cabrera Independent Director
Age: 61
Bio & Compensation  - Reuters
Ganesh M. Kishore Ph.D. Independent Director
Age: 58
Bio & Compensation  - Reuters